Timothy M. Salmon, JD

Co-founder, President & Chief Executive Officer

Tim is a registered U.S. patent attorney with over ten years of experience in patent prosecution, litigation, licensing and due diligence.  In addition to working for law firms in New York City, Tim was in-house patent counsel at Sanofi for several years, supporting Sanofi’s drug/device combination product development, academic collaborations, patent litigations and business development.  Tim has a Bachelor of Science in Biomedical Engineering from the University of Rochester and a Juris Doctor from St. John’s University School of Law.

Robert G. Schaut, PhD

Rob is an immunologist with 11+ years of public and private sector research experience in vaccine development, T cell and B cell biology, and innate immunity. Rob’s expertise lies in innate immune responses to respiratory viruses, molecular cloning and yeast expression systems, adaptive immune responses (including characterization of regulatory T and B cell subsets), pathogen-host interactions and epidemiology, novel vaccine development involving polyanhydride nanovaccines and enteric disease modification to the immune system and microbiome. Rob has a BS in Biochemistry, Cellular and Molecular Biology from Drake University and a PhD in Immunobiology from Iowa State University.

Daniel Mitry, JD

Co-founder, VP of Business Development

Daniel is a registered U.S. patent attorney with extensive experience in patent litigation and licensing. While working at prestigious law firms and as Senior IP Counsel at one of the largest financial software and media companies in the world, Daniel has worked on numerous IP-based business transactions. Daniel has a Bachelor of Science in Computer Science from the University of Maryland and a Juris Doctor from Brooklyn Law School.